The United States has announced a new trade deal with the United Kingdom that includes zero tariffs on pharmaceutical and medical products in exchange for the UK spending more on medicines, the first significant spending increase in more than 20 years, and overhauling how it values drugs.

As part of the deal announced on Monday, the state-run National Health Service (NHS) will spend 25 percent more on treatments for at least the next three years.

“The United States and the United Kingdom announce this negotiated outcome pricing for innovative pharmaceuticals, which will help drive investment and innovation in both countries,” US Trade Representative Jamieson Greer said in a statement.

The USTR statement said the UK would increase the net price it pays for new medicines by 25 percent u

See Full Page